Form D · Biotechnology
SeQure Dx Inc.
Waltham, MA · CIK 0001854843
Offering snapshot reported Dec 22, 2023 · SEC filing
- Reported sold
- $2.18M Offering amount: $5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Nov 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2023 | Initial | $2,177,419 | No comparison | 7 | SEC filing |
| Dec 22, 2023 | Initial | $2,612,903 | No comparison | 7 | SEC filing |
| Apr 6, 2021 | Initial | $17,500,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-500650
Source: Form D, filed Dec 22, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl M. Berke | Director |
| Nancy Hong | Director |
| Sanjay Pothen | Director, Executive |
| Ellen Sheets | Director, Executive |
| Isaac Zike | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1440 Main Street
Waltham, MA, 02451
Waltham, MA, 02451